1. Wieland DM, Brown LE, Tobes MC. Imaging the primate adrenal medulla with 1231 and 1311 meta-iodobenzylguanidine.J Nucl Med 1981; 22:358–364.
2. Solanki KK, Bomanji J, Moyes J, et al. A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG).Nucl Med Commun 1992; 13:513–521.
3. Wafelman AR, Hoefnagel CA, Maes RA, et al. Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry.Eur J Nucl Med 1994; 21:545–559.
4. Glowniak JV, Kilty JE, Amara SG, et al. Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters.J Nucl Med 1993; 34:114–116.
5. Jaques S, Tobes MC, Sisson JC. Sodium dependency of uptake of norepinephrine andm-iodobenzylquanidine into cultured human pheochromocytoma cells: evidence of uptake-one.Cancer Res 1987; 47:3920–3928.